Skip to content

Price / book at other companies

Eli Lilly logo
Eli LillyLLY
26.3×-20.7×
Amgen logo
AmgenAMGN
20.6×-6.3×
Altimmune logo
AltimmuneALT
1.4×-1.3×
Viking Therapeutics logo
Viking TherapeuticsVKTX
7.5×+4.3×
Wave Life Sciences logo
Wave Life SciencesWVE
2.7×-4.6×
Prime Medicine logo
Prime MedicinePRME
8.2×+5.8×

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Calculated from Vivani Medical’s reported figures.

Based on the most recent quarter.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's price / book?
Vivani Medical (VANI) reported price / book of 4.4× in Q1 2026.
How has Vivani Medical's price / book changed year-over-year?
Vivani Medical's price / book decreased by 26.3% year-over-year, from 6× to 4.4×.
What is the long-term trend for Vivani Medical's price / book?
Over 5 years (2020 to 2025), Vivani Medical's price / book has grown at a -43.0% compound annual growth rate (CAGR), from 95.2× to 5.7×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.